menu

Medical Program: The Role of Targeted Therapy in Metastatic Colorectal Cancer Patient Care

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

The Role of Targeted Therapy in Metastatic Colorectal Cancer Patient Care

The Role of Targeted Therapy in Metastatic Colorectal Cancer Patient Care
RestartResume
Looking to provide a more personalized care approach to your metastatic colorectal cancer patients? Here’s what you need to consider.
  • Sponsored by

  • Overview

    From VEGF and EGFR-targeted therapies to emerging immunotherapies, there are several treatment options available to mCRC patients…but that also means that there’s several factors you need to think about before deciding which option is best for each individual patient. Here to break everything down with host Dr. Shira Johnson is Dr. Edmond Bendaly, chairman and liaison of the Cancer Committee at Marion General Hospital in Marion, Indiana.

    Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.